Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Degludec vs Glargine U100 in Ramadan
NCT03349840Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2018
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Weill Cornell Medicine. Started Jan 2018; status: terminated.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03349840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349840.